Regulus Therapeutics Inc (RGLS)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
May 03, 16:00
2.65
0.00 (0.00%)
After-Hours: 19:15
Regulus Therapeutics Max Drawdown (5Y): 99.80% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.80% |
March 31, 2024 | 99.80% |
February 29, 2024 | 99.80% |
January 31, 2024 | 99.80% |
December 31, 2023 | 99.80% |
November 30, 2023 | 99.80% |
October 31, 2023 | 99.80% |
September 30, 2023 | 99.80% |
August 31, 2023 | 99.80% |
July 31, 2023 | 99.80% |
June 30, 2023 | 99.80% |
May 31, 2023 | 99.80% |
April 30, 2023 | 99.80% |
March 31, 2023 | 99.80% |
February 28, 2023 | 99.80% |
January 31, 2023 | 99.80% |
December 31, 2022 | 99.80% |
November 30, 2022 | 99.80% |
October 31, 2022 | 99.80% |
September 30, 2022 | 99.80% |
August 31, 2022 | 99.80% |
July 31, 2022 | 99.80% |
June 30, 2022 | 99.80% |
May 31, 2022 | 99.80% |
April 30, 2022 | 99.80% |
Date | Value |
---|---|
March 31, 2022 | 99.80% |
February 28, 2022 | 99.80% |
January 31, 2022 | 99.80% |
December 31, 2021 | 99.80% |
November 30, 2021 | 99.80% |
October 31, 2021 | 99.80% |
September 30, 2021 | 99.80% |
August 31, 2021 | 99.80% |
July 31, 2021 | 99.80% |
June 30, 2021 | 99.80% |
May 31, 2021 | 99.80% |
April 30, 2021 | 99.80% |
March 31, 2021 | 99.80% |
February 28, 2021 | 99.80% |
January 31, 2021 | 99.80% |
December 31, 2020 | 99.80% |
November 30, 2020 | 99.80% |
October 31, 2020 | 99.80% |
September 30, 2020 | 99.80% |
August 31, 2020 | 99.80% |
July 31, 2020 | 99.80% |
June 30, 2020 | 99.80% |
May 31, 2020 | 99.80% |
April 30, 2020 | 99.80% |
March 31, 2020 | 99.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.68%
Minimum
May 2019
99.80%
Maximum
Dec 2019
99.79%
Average
99.80%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
ACADIA Pharmaceuticals Inc | 77.18% |
ADMA Biologics Inc | 84.77% |
FibroGen Inc | 99.37% |
Protara Therapeutics Inc | 99.25% |
Amylyx Pharmaceuticals Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -47.34 |
Beta (5Y) | 1.595 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 105.0% |
Historical Sharpe Ratio (5Y) | -0.2816 |
Historical Sortino (5Y) | -0.6427 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.65% |